We always promise
the best care

OBGYN(Gynecologic Oncology Center) Prof. Han, Kyung Hee

Schedule Mon Tues Wed Thurs Fri Sat
AM
PM

Specialty

Robotic/laparoscopic/single-port access surgery, Gynecologic cancer, Uterine myoma, Endometriosis, Abnormal cervical papilla, tumor in childbearing age, Uterovaginal prolapse

Professor Career

  • Seoul National University
  • Inha University
  • CHA University

Medical Experience

  • Seoul National University Gangnam center
  • OBGY, Inha University hospital
  • OBGY, CHA Ilsan medical center, CHA University
  • Gynecologic oncology center, CHA Ilsan medical center, CHA University

Society, Research, Training, Awards

  • Secretary General, The Korean Geriatric Women Medical Association
  • Official commendation, Seoul sunflower Center Serving Victims of Sexual Violence, Ministry of Health and Welfare, 2012

  • Paper
  1. Association between glycemic status and the risk of gastric cancer in pre/peri-and postmenopausal women: A nationwide cohort study. Ann Epidemiol. 2024 Jun;94:106-112.
  2. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study. Maturitas. 2024 Jun;184:107960.
  3. Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol. 2024 May 11;187:85-91.
  4. Effect of air temperature on serum 25-hydroxyvitamin D concentrations: A single institutional large-scale study in Korea. PLoS One. 2024 Mar 29;19(3):e0297495.
  5. The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system? J Gynecol Oncol. 2024 Jan 22.
  6. Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis. Int J Gynecol Cancer 2023, 4;33(12):1913-1920.
  7. The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4. J Gynecol Oncol. 2019 Nov;30(6):e83
  8. Relationship between serum anti-Mullerian hormone with vitamin D and metabolic syndrome risk factors in late reproductive-age women. Gynecol Endocrinol. 2018 Apr:1-5.
  9. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA andIB. Medicine (Baltimore). 2017 May;96(21):e6976.
  10. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017 Jun;45(11):1403-1412.
  11. Expression of aurora kinases: Predictor of tumor dissemination in uterine carcinosarcoma. Histol Histopathol. 2017 Jul;32(7):717-724.
  12. Analysis of the Vaginal Microbiome by Next-Generation Sequencing and Evaluation of its Performance as a Clinical Diagnostic Tool in Vaginitis. Ann Lab Med. 2016 Sep;36(5):441-9
  13. Peritoneal cytology: A risk factor of recurrence for non-endometrioid endometrial cancer. Gynecol Oncol. 2014;134(2):293-6.
  14. Protective Effect of Progesterone during Pregnancy against Ovarian Cancer. J Cancer Prev. 2013 Jun;18(2):113-22.
  15. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. Gynecol Oncol. 2011;120(2):270-4.
  16. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Eur J Surg Oncol. 2010;36(7):691-8.
  17. A study of sexual assault: Based on data from Boramae One-stop Service Center. J Womens Med. 2010;3(3):96-101.
  18. A third stage pelvic organ prolapse due to cervical swelling during labor: A case report. Korean J Obstet Gynecol. 2010;53(8):727-31.